ANAVEX LIFE SCIENCES CORP (AVXL)       9.58  -2.47 (-20.5%)

9.58  -2.47 (-20.5%)

US0327973006 - Common Stock - After market: 9.6 +0.02 (+0.21%)

News Image
9 hours ago - Chartmill

These stocks are moving in today's session

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

News Image
11 hours ago - Chartmill

Which stocks have an unusual volume on Monday?

Let's have a look at the stocks with an unusual volume in today's session.

News Image
3 days ago - The Motley Fool

Is Anavex Life Sciences a Smart Stock to Buy Now?

The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it?

News Image
3 days ago - Anavex Life Sciences Corp.

Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022

Webcast and Conference Call To be Held Monday December 5, 2022, 8:30 am ET...

News Image
3 days ago - Chartmill

Friday's session: top gainers and losers

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

News Image
3 days ago - Chartmill

Which stocks are moving on Friday?

Let's have a look at the top gainers and losers in the middle of the day of today's session.

News Image
4 days ago - The Motley Fool

Why Anavex Life Sciences Stock Is Surging Today

The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate.

News Image
4 days ago - InvestorPlace

Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News

Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment.

News Image
4 days ago - InvestorPlace

Why Is Anavex Life Sciences (AVXL) Stock Up 30% Today?

Anavex Life Sciences (AVXL) stock is rocketing higher on Friday following positive results from an Alzheimer’s clinical trial.

News Image
4 days ago - Investor's Business Daily

Anavex Catapults On Alzheimer's Results — But Math Question Clouds The Data

A math error could have clouded the drug's actual benefits.

News Image
4 days ago - Chartmill

Gapping stocks in Friday's session

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

News Image
4 days ago - Chartmill

What's going on in today's pre-market session

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image
4 days ago - Seeking Alpha

Jones sees Anavex as 'clear M&A target' after Alzheimer's drug's trial success

Anavex Life Sciences (AVXL) stock rose ~58% premarket after its oral drug ANAVEX2-73 (blarcamesine) met the main goal of a phase 2B/3 trial in patients with early Alzheimer's disease,...

News Image
4 days ago - Seeking Alpha

Anavex drug improves cognitive function in Alzheimer's patients, meets main goal of trial

Anavex Life Sciences (AVXL) said its oral drug ANAVEX2-73 (blarcamesine) met the main goal of improvement in cognitive function in patients with early Alzheimer's disease ((AD)) in a...

News Image
4 days ago - Anavex Life Sciences Corp.

ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease

Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADLKey Secondary...

News Image
6 days ago - Seeking Alpha

AVXL stock defended at Cantor on prospects for rare disease therapy (NASDAQ:AVXL)

Following a selloff in the previous session, Anavex Life Sciences (AVXL) recovered on Tuesday as Cantor Fitzgerald reaffirmed its Overweight recommendation citing the biotech’s...

News Image
7 days ago - The Motley Fool

Why Shares of Anavex Life Sciences Slumped 23.5% on Monday

The company released its fourth-quarter and full-year numbers.

News Image
7 days ago - Chartmill

Which stocks are moving on Monday?

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

News Image
7 days ago - Seeking Alpha

Hot Stocks: BYND, TSN drop on downgrade; BUD upgrade; AVXL slumps on business update

BYND and TSN dropped on an analyst's downgrade. BUD climbed on an upgrade. AVXL lost ground following a business update. PTON rose on post-Black Friday hope for exercise products.

News Image
7 days ago - Market News Video

AVXL Crosses Below Key Moving Average Level

News Image
8 days ago - Seeking Alpha

AVXL stock drops after fiscal 2022 update (NASDAQ:AVXL)

Anavex Life Sciences Corp. (AVXL), a neurology-focused biotech, lost ~16% on Monday Morning after the company announced fiscal 2022 financials and issued a business update, highlights...

News Image
8 days ago - Seeking Alpha

Anavex Life Sciences GAAP EPS of -$0.18 misses by $0.01 (NASDAQ:AVXL)

Anavex Life Sciences press release (AVXL): Q4 GAAP EPS of -$0.18 misses by $0.01.Cash and cash equivalents of $149.2M.“This is an exciting time in neuroscience and rare disease...

News Image
8 days ago - Anavex Life Sciences Corp.

Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update

Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the...